Alerus Financial NA Purchases 6,186 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Alerus Financial NA boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 177.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,678 shares of the medical equipment provider's stock after purchasing an additional 6,186 shares during the quarter. Alerus Financial NA's holdings in Intuitive Surgical were worth $5,052,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the 4th quarter worth $36,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company's stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 492 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $282,299.76. Following the completion of the transaction, the senior vice president now directly owns 4,056 shares of the company's stock, valued at approximately $2,327,251.68. This represents a 10.82 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Remove Ads

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $0.87 during mid-day trading on Tuesday, hitting $494.40. 634,248 shares of the company's stock were exchanged, compared to its average volume of 1,526,712. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business has a fifty day moving average price of $554.33 and a 200 day moving average price of $532.98. The company has a market cap of $176.09 billion, a PE ratio of 77.31, a P/E/G ratio of 5.85 and a beta of 1.43.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ISRG. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.